HIMS & HERS HEALTH, INC.
HIMS · Healthcare · $8.5B mkt cap · FY2025 filings · Shallow moat ·
Doesn't clear the bar
The four filters
Median gross margin 75.2% over 7y, stable.
Median ROIC -9.4%, above the 9% hurdle in 40% of years.
Net cash position — no leverage risk.
Owner earnings trend unclear, share count growing (dilution).
Margin of safety
- Owner earnings (normalized)
- —
- Est. intrinsic value / share
- —
- Recent price
- $32.84
- Discount to value
- No price data
Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).
8 years of fundamentals
The business, in plain English
HIMS & HERS HEALTH, INC. booked $2.3B of revenue in FY2025 in the Healthcare sector and kept 73.8% of it as gross profit — a high-margin business by that measure. After every other cost, 5.5% of each revenue dollar reached the bottom line.
Across the filed record, revenue grew from $82.6M (FY2019) to $2.3B (FY2025) — about 74.7% a year compounded over 6 years.
It earned 33.8% on invested capital in FY2025, with a median of −9.4% across 5 filed years. The Returns on Capital filter above scores it 14/100.
HIMS's filings don't disclose total debt in a form the methodology can use, so leverage is treated as unmeasured — never assumed to be zero.
The share count rose 642.9% between FY2019 and FY2025 — existing owners have been diluted over the record. Capital Discipline scores it 24/100.
Put together: Balance-Sheet Safety is the strongest of the four filters (100/100) and Returns on Capital the weakest (14/100), which is how HIMS lands at 56/100 — a Shallow moat.
This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.
Gaps in a line mean that item isn’t in HIMS’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.
Moat Score history
Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
None yet — HIMS has read Shallow moat for every logged capture since Jul 17, 2026.
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Healthcare context
#94 of 440 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #92TDY TELEDYNE TECHNOLOGIES INC55.9 out of 100, Shallow moatShallow moat
- #93BRKR BRUKER CORPORATION55.9 out of 100, Shallow moatShallow moat
- #95PLX PROTALIX BIOTHERAPEUTICS, INC.55.7 out of 100, Shallow moatShallow moat
- #96RIGL RIGEL PHARMACEUTICALS INC55.2 out of 100, Shallow moatShallow moat
Compare HIMS with its nearest peers →All Healthcare companies on the Index →
Common questions about HIMS
- Does HIMS & HERS HEALTH, INC. have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores HIMS & HERS HEALTH, INC. (HIMS) 55.8 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 89, returns on capital 14, balance-sheet safety 100, capital discipline 24.
- How has HIMS's Moat Score changed over time?
- The record logs 3 readings since Jul 17, 2026; the latest reads 55.8 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.